COSMO Pharmaceuticals Operating Profit Margin History

COPN Stock  CHF 75.80  -3.20  -4.05%   
COSMO Pharmaceuticals' Operating Profit Margin trajectory is shaped by both internal decisions and external market forces. COSMO Pharmaceuticals last reported Operating Profit Margin of -0.095, moving down 5.24% from -0.1 in the year before. COSMO Pharmaceuticals' Operating Profit Margin is developing negatively compared to prior years.
Structural changes in COSMO Pharmaceuticals' business tend to show up in Operating Profit Margin over time. The most recent reading gains meaning when set against the full distribution of past values.

Latest COSMO Pharmaceuticals' Operating Profit Margin Growth Pattern

COSMO Pharmaceuticals' Operating Profit Margin trend is developing negatively over the charted period. Year-over-year movement was 5.24%, a decrease from the prior period. Inflection points in COSMO Pharmaceuticals' Operating Profit Margin often correspond to material business events or reporting changes.
Operating Profit Margin10 Years Trend
Pretty Stable
The dataset reflects standardized financial reporting inputs across periods.
   Operating Profit Margin   
       Timeline  

Operating Profit Margin Trend Statistics

Arithmetic Mean 0.35
Geometric Mean 0.23
Coefficient Of Variation 286.92
Mean Deviation 0.48
Median 0.17
Standard Deviation 1.00
Sample Variance 1.01
Range4.3832
R-Value-0.19
Mean Square Error 1.03
R-Squared 0.04
Significance 0.46
Slope-0.04
Total Sum of Squares 16.10

COSMO Pharmaceuticals Operating Profit Margin History

2026 -0.095
2025 -0.1
2024 0.56
2023 0.0662
2022 0.27
2021 0.17
2020 0.11
2019 -0.2
2018 -0.25
2017 -0.23
2016 0.31
2015 4.13
2014 0.28
2013 0.23
2012 0.44

Related Accounts

Methodology, Assumptions & Data Sources

A look at COSMO Pharmaceuticals's Operating Profit Margin over multiple years is shown here. The slope of the line shows how fast things are changing.

This section for COSMO Pharmaceuticals SA is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.

This content is curated and reviewed by:

Raphi Shpitalnik - Junior Member of Macroaxis Editorial Board
Last reviewed on March 10th, 2026